Skip to main content
. 2016 Jan 14;22(2):764–775. doi: 10.3748/wjg.v22.i2.764

Table 3.

Baseline characteristics of the Patients in the ACCORD-11 and MPACT trials

Variable ACCORD-11(FOLFIRINOX) MPACT (Gemcitabine-Nab-paclitaxel)
Age
Median year (min, max) 61 (25, 76) 63 (27, 88)
≥ 65-yr-old 29.0% 42%
≥ 75-yr-old - 10%
Performance status (ECOG)
0 37.4% 16%
1 61.9% 44%
2 32%
3 7%